Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2026-01-16 @ 7:24 AM
Study NCT ID:
NCT00573794
Status:
COMPLETED
Last Update Posted:
2021-07-07
First Post:
2007-12-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2016-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12
Completion Date Type:
ACTUAL
First Submit Date:
2007-12-12
First Submit QC Date:
None
Study First Post Date:
2007-12-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-11-21
Results First Submit QC Date:
None
Results First Post Date:
2017-12-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-02
Last Update Post Date:
2021-07-07
Last Update Post Date Type:
ACTUAL